BCL2 and leukemia: Novel transferrin receptor-targeted liposomes delivered phosphorothioate antisense oligodeoxyribonucleotide (ODN-G3139) in TfR positive K562 leukemia cells and downregulated Bcl-2 protein in K562 cells 2-fold greater than non-targeted liposomes and 10-fold greater than free G3139.